文献速递泌尿生殖MR

DCE-MRI能否减少PI-RADS v.2假阳性发现?定量药代动力学参数在前列腺病灶表征中的作用

Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization.
PubMed 文献 · Eur J Radiol · 2019-07-02

回顾性纳入103例接受多参数前列腺MRI及组织学评估的男性,评估DCE-MRI药代动力学参数(Ktrans、Kep、Ve、Vp)对PI-RADS v.2诊断显著肿瘤(GS≥7)性能的影响。Ktrans截断值191×10⁻³/min预测GS≥7的AUC为0.75、敏感度95%、特异度61%;按此截断值重新分类PI-RADS≥3病灶后,22例假阳性转为真阴性、3例假阴性,PPV由61%升至79%。作者认为Ktrans联合PI-RADS v.2似乎可提高MRI-PPV并可能有助于避免不必要的活检。

要点

  • GS≥7病灶的Ktrans(p<0.01)和Kep(p=0.01)均高于GS<7病灶。
  • Ktrans截断值191×10⁻³/min预测GS≥7的AUC为0.75、敏感度95%、特异度61%。
  • 按Ktrans截断值重新分类后PPV由61%升至79%,但出现3例假阴性。

核心结论

  • 前列腺mpMRI虽敏感度高(98%)但假阳性多,Ktrans联合PI-RADS v.2似乎可提高MRI-PPV并可能有助于避免不必要的活检。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2018年3月接受多参数前列腺MRI并随后行靶向活检或前列腺切除术的103例男性。
  • 对每例患者识别指数病灶并评估药代动力学参数Ktrans、Kep、Ve、Vp。
  • 以PI-RADS≥3为阳性,评估MRI检测显著肿瘤(GS≥7)的诊断性能,参考标准为组织学评估。

关键影像表现/征象

  • 原文未报告影像征象描述。

诊断标准与关键数值

  • GS≥7组(n=59)Ktrans(p<0.01)和Kep(p=0.01)高于GS<7组。
  • Ktrans截断值191×10⁻³/min预测GS≥7的AUC为0.75、敏感度95%、特异度61%。
  • mpMRI采用PI-RADS v.2的敏感度为98%、PPV为61%。
  • 按Ktrans截断值重新分类PI-RADS≥3病灶后,22例假阳性转为真阴性、3例假阴性,PPV升至79%。
  • 对PI-RADS 3的外周带病灶(n=18)应用Ktrans截断值,识别出12例真阴性、4例真阳性、2例假阳性。

临床应用与阅片要点

  • 作者认为Ktrans联合PI-RADS v.2似乎可提高MRI-PPV并可能有助于避免不必要的活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To test the potential impact of pharmacokinetic parameters, derived from DCE-MRI analysis, on the diagnostic performance of PI-RADSv.2 classification in prostate lesions characterization.

METHOD: Among patients who underwent multiparametric prostate MRI (mpMRI) (January 2016-March 2018) followed by histological evaluation (targeted biopsies/prostatectomy), 103 men were retrospectively selected. For each patient the index lesion was identified and pharmacokinetic parameters (Ktrans, Kep, Ve, Vp) were assessed. MRI diagnostic performance in the detection of significant tumors [Gleason Score (GS)≥7] was assessed, considering PI-RADS≥3 as positive.

RESULTS: GS ≥ 7 (n = 59) showed higher Ktrans (p < 0.01) and Kep (p = 0.01) compared to GS < 7. At ROC curve analysis, a Ktrans cut-off of 191 × 10-3/min was identified to predict the presence of GS ≥ 7 (AUC:0.75; sensitivity:95%; specificity:61%). Sensitivity and PPV of mpMRI using PI-RADSv.2 were 98% and 61%. Reclassifying PI-RADS≥3 lesions according to Ktrans cut-off, 22 false positives were shifted to true negatives with 3 false negative findings; PPV raised to 79%. Appling Ktrans cut-off to PI-RADS 3 lesions of peripheral zone (n = 18), 12 true negatives, 4 true positives, 2 false positives were identified.

CONCLUSIONS: Despite its high sensitivity prostate mpMRI generates many false positive cases: Ktrans in addition to PIRADS v.2 seems to improve MRI-PPV and may help in avoiding redundant biopsies.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Cristel G, Esposito A, Damascelli A, et al. Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization. Eur J Radiol. 2019. PMID: 31439258. doi:10.1016/j.ejrad.2019.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。